The survey is anticipated to be accomplished in 12 days, a BMC official mentioned. (Representational picture)
Mumbai:
The Mumbai civic physique has began the second part of sero-surveillance research within the metropolis from Monday to evaluate the unfold of COVID-19 and the way many individuals have developed antibodies in opposition to the illness.
The survey will cowl F-North (Dadar, Matunga and Dharavi), M-West (Deonar and Govandi) and R-North (Dahisar) wards, the place an identical research was performed final month, a Brihanmumbai Municipal Company (BMC) official mentioned.
The research will present details about the unfold of the an infection and likewise throw gentle on herd immunity, he mentioned.
“The sero-surveillance research will give an perception into the unfold of COVID-19 and improvement of antibodies. The paper work for the survey has begun from at present,” Extra Municipal Commissioner Suresh Kakani mentioned.
If every part goes as per the plan, the survey is anticipated to be accomplished in 12 days, he mentioned.
A serological survey includes testing of blood serum of people to test for the prevalence of antibodies in opposition to an an infection.
The sero survey performed within the first half of July revealedthat 57 per cent of slum inhabitants and 16 per cent of non-slum residents within the three civic wards had developed antibodies. It confirmed excessive proportion of asymptomatic COVID-19 an infection within the metropolis.
Through the research final month, 6,936 samples out of an estimated eight,870 had been collected from slum and non-slum inhabitants of the three civic wards.
The serological surveillance for SARS-CoV2 an infection has been collectively commissioned by the NITI Aayog, the BMC and the Tata Institute of Basic Analysis (TIFR).
The research is being carried out in collaboration with organisations just like the Kasturba Molecular Diagnostic Laboratory, Translational Well being Science and Expertise Institute (THSTI), A T E Chandra Basis and IDFC Institute.
Source link
